Hugel Inc.

Hugel Inc.
Stock Exchange Korea Exchange
EPS
KRW16028
Market Cap
KRW1.9 T
Shares Outstanding
4.36 M
Public Float
2.29 M

Profile

Address
61-20 Sinbuk-ro
Chuncheon-si GA 24206
Korea, Republic Of
Employees -
Website http://www.hugel.co.kr
Updated 09/14/2018
Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. Its products include botulinum toxin, hyaluronic acid fillers, facial masks, concealers, and moisturizers. The company was founded on November 22, 2001 and is headquartered in Chuncheon-si, South Korea.

Financials

View All

Ji-Hun Son
Chief Executive Officer & Director
Do-Hyeon Kim
Director & Head-Finance